Sepsis-Associated Encephalopathy and Blood-Brain Barrier Dysfunction.
Qingzeng GaoMarina Sorrentino HernandesPublished in: Inflammation (2021)
Sepsis is a life-threatening clinical condition caused by a dysregulated host response to infection. Sepsis-associated encephalopathy (SAE) is a common but poorly understood neurological complication of sepsis, which is associated with increased morbidity and mortality. SAE clinical presentation may range from mild confusion and delirium to severe cognitive impairment and deep coma. Important mechanisms associated with SAE include excessive microglial activation, impaired endothelial barrier function, and blood-brain barrier (BBB) dysfunction. Endotoxemia and pro-inflammatory cytokines produced systemically during sepsis lead to microglial and brain endothelial cell activation, tight junction downregulation, and increased leukocyte recruitment. The resulting neuroinflammation and BBB dysfunction exacerbate SAE pathology and aggravate sepsis-induced brain dysfunction. In this mini-review, recent literature surrounding some of the mediators of BBB dysfunction during sepsis is summarized. Modulation of microglial activation, endothelial cell dysfunction, and the consequent prevention of BBB permeability represent relevant therapeutic targets that may significantly impact SAE outcomes.
Keyphrases
- blood brain barrier
- cerebral ischemia
- septic shock
- acute kidney injury
- intensive care unit
- endothelial cells
- oxidative stress
- cognitive impairment
- lps induced
- lipopolysaccharide induced
- inflammatory response
- cardiac surgery
- early onset
- systematic review
- high glucose
- traumatic brain injury
- cell proliferation
- body mass index
- signaling pathway
- multiple sclerosis
- adipose tissue
- resting state
- skeletal muscle
- white matter
- metabolic syndrome
- anti inflammatory
- drug induced
- stress induced